Press Release

<< Back

Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

April 25, 2022

BURNABY, British Columbia, April 25, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company today announced that Xenon’s management team will participate in the following investor conferences:

Jefferies Biotech on the Bay Summit 
Date/Location: April 26-27, 2022 in Miami, FL (one-on-one investor meetings only)
Bloom Burton & Co. Healthcare Investor Conference 2022 
May 2-3, 2022 at the Metro Toronto Convention Centre in Toronto, ON
Presentation: Tuesday, May 3, 2022
Time: 11:30 am Eastern Time
2022 RBC Capital Markets Global Healthcare Conference 
Date/Location: May 17-18, 2022 at the InterContinental Barclay in New York, NY
Fireside Chat: Wednesday, May 18, 2022
Time: 11:00 am Eastern Time

Details on company presentations and webcasts can be found on the “Investors” section of Xenon’s website at When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353

Primary Logo

Source: Xenon Pharmaceuticals Inc.